Todd E. Simpson, Chief Financial Officer at SEATTLE GENETICS INC /WA (SGEN), sold 53,201 shares at $147.00 ($8.4M) on 2020-05-04, disclosed to the SEC on 2020-05-06.
Open-market sale of $8.4M SGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.00 | 14,167 | $2.1M | 24.7% |
| 2 | $162.45 | 13,500 | $2.2M | 26.0% |
| 3 | $163.36 | 12,167 | $2.0M | 23.5% |
| 4 | $163.36 | 12,167 | $2.0M | 23.5% |
| 5 | $164.10 | 1,200 | $197K | 2.3% |
| Total | $158.79 avg | 53,201 |
| $8.4M |
| 100% |
| Filing → |
| SGEN | SELL | 2023-08-30 | $100K | — | Filing → |
| SGEN | SELL | 2023-04-12 | $22.6M | — | Filing → |
| SGEN | SELL | 2023-04-07 | $100K | — | Filing → |